Annual EBIT
$7.76 B
-$2.97 B-27.64%
December 31, 2024
Summary
- As of February 7, 2025, AMGN annual earnings before interest & taxes is $7.76 billion, with the most recent change of -$2.97 billion (-27.64%) on December 31, 2024.
- During the last 3 years, AMGN annual EBIT has fallen by -$134.00 million (-1.70%).
- AMGN annual EBIT is now -29.01% below its all-time high of $10.94 billion, reached on December 31, 2018.
Performance
AMGN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$1.53 B
-$2.35 B-60.56%
December 31, 2024
Summary
- As of February 7, 2025, AMGN quarterly earnings before interest & taxes is $1.53 billion, with the most recent change of -$2.35 billion (-60.56%) on December 31, 2024.
- Over the past year, AMGN quarterly EBIT has dropped by -$144.00 million (-8.61%).
- AMGN quarterly EBIT is now -61.63% below its all-time high of $3.98 billion, reached on March 31, 2023.
Performance
AMGN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$7.76 B
-$144.00 M-1.82%
December 31, 2024
Summary
- As of February 7, 2025, AMGN TTM earnings before interest & taxes is $7.76 billion, with the most recent change of -$144.00 million (-1.82%) on December 31, 2024.
- Over the past year, AMGN TTM EBIT has dropped by -$2.97 billion (-27.64%).
- AMGN TTM EBIT is now -31.13% below its all-time high of $11.27 billion, reached on June 30, 2023.
Performance
AMGN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AMGN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.6% | -8.6% | -27.6% |
| 3 y3 years | -1.7% | -38.0% | -1.7% |
| 5 y5 years | -25.5% | -33.1% | -25.5% |
AMGN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.6% | at low | -61.6% | +102.3% | -31.1% | +15.2% |
| 5 y | 5-year | -27.6% | at low | -61.6% | +102.3% | -31.1% | +15.2% |
| alltime | all time | -29.0% | >+9999.0% | -61.6% | +2160.7% | -31.1% | >+9999.0% |
Amgen EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $7.76 B(-27.6%) | $1.53 B(-60.6%) | $7.76 B(-1.8%) |
| Sep 2024 | - | $3.88 B(+142.0%) | $7.91 B(+17.4%) |
| Jun 2024 | - | $1.60 B(+111.9%) | $6.74 B(-10.2%) |
| Mar 2024 | - | $756.00 M(-54.8%) | $7.50 B(-30.1%) |
| Dec 2023 | $10.73 B(+22.6%) | $1.67 B(-38.2%) | $10.73 B(-4.4%) |
| Sep 2023 | - | $2.71 B(+14.4%) | $11.22 B(-0.5%) |
| Jun 2023 | - | $2.37 B(-40.6%) | $11.27 B(+4.7%) |
| Mar 2023 | - | $3.98 B(+84.2%) | $10.77 B(+23.0%) |
| Dec 2022 | $8.75 B(+10.8%) | $2.16 B(-21.6%) | $8.75 B(-3.3%) |
| Sep 2022 | - | $2.76 B(+48.5%) | $9.05 B(+3.5%) |
| Jun 2022 | - | $1.86 B(-5.6%) | $8.75 B(+13.2%) |
| Mar 2022 | - | $1.97 B(-20.1%) | $7.73 B(-2.2%) |
| Dec 2021 | $7.90 B(-15.9%) | $2.47 B(+0.6%) | $7.90 B(+3.6%) |
| Sep 2021 | - | $2.45 B(+192.1%) | $7.63 B(-0.7%) |
| Jun 2021 | - | $839.00 M(-60.8%) | $7.68 B(-16.2%) |
| Mar 2021 | - | $2.14 B(-2.4%) | $9.17 B(-2.4%) |
| Dec 2020 | $9.39 B(-9.9%) | $2.19 B(-12.5%) | $9.39 B(-0.9%) |
| Sep 2020 | - | $2.51 B(+7.8%) | $9.48 B(-0.9%) |
| Jun 2020 | - | $2.33 B(-1.7%) | $9.57 B(-5.6%) |
| Mar 2020 | - | $2.37 B(+3.6%) | $10.14 B(-2.8%) |
| Dec 2019 | $10.43 B(-4.7%) | $2.28 B(-11.8%) | $10.43 B(-2.4%) |
| Sep 2019 | - | $2.59 B(-10.6%) | $10.68 B(+1.3%) |
| Jun 2019 | - | $2.90 B(+9.0%) | $10.54 B(-0.9%) |
| Mar 2019 | - | $2.66 B(+4.7%) | $10.64 B(-2.7%) |
| Dec 2018 | $10.94 B(+0.3%) | $2.54 B(+3.6%) | $10.94 B(-0.1%) |
| Sep 2018 | - | $2.45 B(-18.2%) | $10.95 B(-2.3%) |
| Jun 2018 | - | $2.99 B(+1.3%) | $11.20 B(+1.2%) |
| Mar 2018 | - | $2.96 B(+16.1%) | $11.07 B(+1.6%) |
| Dec 2017 | $10.90 B(+4.6%) | $2.55 B(-5.9%) | $10.90 B(-0.6%) |
| Sep 2017 | - | $2.71 B(-5.5%) | $10.97 B(-0.3%) |
| Jun 2017 | - | $2.86 B(+2.8%) | $11.00 B(+3.2%) |
| Mar 2017 | - | $2.79 B(+6.7%) | $10.66 B(+2.2%) |
| Dec 2016 | $10.42 B(+14.9%) | $2.61 B(-4.8%) | $10.42 B(+4.1%) |
| Sep 2016 | - | $2.74 B(+9.0%) | $10.01 B(+2.8%) |
| Jun 2016 | - | $2.52 B(-1.4%) | $9.74 B(+2.6%) |
| Mar 2016 | - | $2.55 B(+16.2%) | $9.50 B(+4.7%) |
| Dec 2015 | $9.07 B(+36.3%) | $2.20 B(-11.2%) | $9.07 B(+7.7%) |
| Sep 2015 | - | $2.47 B(+8.8%) | $8.42 B(+11.5%) |
| Jun 2015 | - | $2.27 B(+6.9%) | $7.55 B(+3.2%) |
| Mar 2015 | - | $2.13 B(+37.6%) | $7.32 B(+10.0%) |
| Dec 2014 | $6.66 B(+5.9%) | $1.55 B(-3.7%) | $6.66 B(+4.3%) |
| Sep 2014 | - | $1.61 B(-21.3%) | $6.38 B(-2.4%) |
| Jun 2014 | - | $2.04 B(+39.4%) | $6.54 B(+6.4%) |
| Mar 2014 | - | $1.46 B(+14.7%) | $6.14 B(-2.3%) |
| Dec 2013 | $6.29 B(+3.7%) | $1.27 B(-27.6%) | $6.29 B(+1.0%) |
| Sep 2013 | - | $1.76 B(+6.9%) | $6.23 B(+3.8%) |
| Jun 2013 | - | $1.65 B(+2.5%) | $6.00 B(-1.1%) |
| Mar 2013 | - | $1.61 B(+32.3%) | $6.07 B(+0.1%) |
| Dec 2012 | $6.06 B(+27.4%) | $1.21 B(-20.9%) | $6.06 B(-0.5%) |
| Sep 2012 | - | $1.53 B(-10.4%) | $6.09 B(+17.8%) |
| Jun 2012 | - | $1.71 B(+7.0%) | $5.17 B(+5.1%) |
| Mar 2012 | - | $1.60 B(+28.5%) | $4.92 B(+3.4%) |
| Dec 2011 | $4.76 B(-19.6%) | $1.25 B(+103.6%) | $4.76 B(+1.8%) |
| Sep 2011 | - | $612.00 M(-58.1%) | $4.67 B(-17.2%) |
| Jun 2011 | - | $1.46 B(+1.4%) | $5.65 B(-2.6%) |
| Mar 2011 | - | $1.44 B(+24.1%) | $5.80 B(-0.7%) |
| Dec 2010 | $5.92 B(+2.4%) | $1.16 B(-26.7%) | $5.84 B(-1.0%) |
| Sep 2010 | - | $1.58 B(-1.7%) | $5.89 B(-1.6%) |
| Jun 2010 | - | $1.61 B(+8.8%) | $5.99 B(+1.8%) |
| Mar 2010 | - | $1.48 B(+21.7%) | $5.88 B(+1.8%) |
| Dec 2009 | $5.78 B(+3.9%) | $1.22 B(-27.5%) | $5.78 B(-4.5%) |
| Sep 2009 | - | $1.68 B(+11.4%) | $6.05 B(+3.3%) |
| Jun 2009 | - | $1.51 B(+9.3%) | $5.86 B(+5.9%) |
| Mar 2009 | - | $1.38 B(-7.4%) | $5.53 B(-0.6%) |
| Dec 2008 | $5.57 B(+16.5%) | $1.49 B(+0.4%) | $5.57 B(+4.2%) |
| Sep 2008 | - | $1.48 B(+25.8%) | $5.34 B(+10.3%) |
| Jun 2008 | - | $1.18 B(-16.7%) | $4.84 B(+1.0%) |
| Mar 2008 | - | $1.42 B(+11.8%) | $4.79 B(+0.3%) |
| Dec 2007 | $4.78 B(-5.8%) | $1.27 B(+28.8%) | $4.78 B(-16.6%) |
| Sep 2007 | - | $983.00 M(-13.0%) | $5.73 B(-5.6%) |
| Jun 2007 | - | $1.13 B(-19.3%) | $6.07 B(-4.2%) |
| Mar 2007 | - | $1.40 B(-36.9%) | $6.34 B(+2.7%) |
| Dec 2006 | $5.07 B(+4.6%) | $2.22 B(+67.9%) | $6.17 B(+22.1%) |
| Sep 2006 | - | $1.32 B(-5.3%) | $5.05 B(+0.5%) |
| Jun 2006 | - | $1.40 B(+13.1%) | $5.03 B(+2.1%) |
| Mar 2006 | - | $1.23 B(+12.1%) | $4.93 B(+1.6%) |
| Dec 2005 | $4.85 B(+24.2%) | $1.10 B(-15.2%) | $4.85 B(-7.1%) |
| Sep 2005 | - | $1.30 B(+0.4%) | $5.22 B(+18.2%) |
| Jun 2005 | - | $1.29 B(+11.9%) | $4.42 B(+6.9%) |
| Mar 2005 | - | $1.16 B(-21.5%) | $4.13 B(+5.8%) |
| Dec 2004 | $3.90 B | $1.47 B(+198.2%) | $3.90 B(+22.6%) |
| Sep 2004 | - | $494.00 M(-50.9%) | $3.18 B(-10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2004 | - | $1.01 B(+8.5%) | $3.55 B(+5.7%) |
| Mar 2004 | - | $928.00 M(+22.9%) | $3.36 B(+8.6%) |
| Dec 2003 | $3.09 B(+40.1%) | $755.00 M(-11.9%) | $3.09 B(+3.5%) |
| Sep 2003 | - | $857.00 M(+4.9%) | $2.99 B(+12.1%) |
| Jun 2003 | - | $817.10 M(+23.4%) | $2.66 B(+10.5%) |
| Mar 2003 | - | $662.20 M(+1.7%) | $2.41 B(+9.3%) |
| Dec 2002 | $2.21 B(+44.1%) | $651.10 M(+22.0%) | $2.21 B(+25.0%) |
| Sep 2002 | - | $533.70 M(-5.5%) | $1.76 B(+4.6%) |
| Jun 2002 | - | $564.80 M(+23.5%) | $1.69 B(+7.3%) |
| Mar 2002 | - | $457.40 M(+118.7%) | $1.57 B(+2.7%) |
| Dec 2001 | $1.53 B(+11.9%) | $209.10 M(-54.2%) | $1.53 B(-5.3%) |
| Sep 2001 | - | $456.20 M(+1.5%) | $1.62 B(+4.4%) |
| Jun 2001 | - | $449.40 M(+7.9%) | $1.55 B(+6.2%) |
| Mar 2001 | - | $416.50 M(+40.9%) | $1.46 B(+3.4%) |
| Dec 2000 | $1.37 B(+3.3%) | $295.60 M(-23.7%) | $1.41 B(-2.4%) |
| Sep 2000 | - | $387.60 M(+8.2%) | $1.45 B(+2.3%) |
| Jun 2000 | - | $358.30 M(-2.9%) | $1.41 B(+1.5%) |
| Mar 2000 | - | $368.90 M(+11.6%) | $1.39 B(+5.0%) |
| Dec 1999 | $1.32 B(+18.5%) | $330.60 M(-7.0%) | $1.32 B(+2.5%) |
| Sep 1999 | - | $355.60 M(+5.6%) | $1.29 B(+5.1%) |
| Jun 1999 | - | $336.80 M(+11.5%) | $1.23 B(+4.6%) |
| Mar 1999 | - | $302.00 M(+1.3%) | $1.18 B(+5.1%) |
| Dec 1998 | $1.12 B(+20.2%) | $298.00 M(+1.8%) | $1.12 B(+7.2%) |
| Sep 1998 | - | $292.80 M(+3.5%) | $1.04 B(+7.8%) |
| Jun 1998 | - | $282.80 M(+15.5%) | $967.70 M(+2.5%) |
| Mar 1998 | - | $244.80 M(+9.9%) | $943.90 M(+1.5%) |
| Dec 1997 | $930.30 M(+1.6%) | $222.80 M(+2.5%) | $930.30 M(-1.2%) |
| Sep 1997 | - | $217.30 M(-16.1%) | $942.00 M(-1.8%) |
| Jun 1997 | - | $259.00 M(+12.0%) | $959.10 M(+2.3%) |
| Mar 1997 | - | $231.20 M(-1.4%) | $937.90 M(+4.1%) |
| Dec 1996 | $916.00 M(+20.4%) | $234.50 M(+0.0%) | $901.10 M(+3.9%) |
| Sep 1996 | - | $234.40 M(-1.4%) | $867.30 M(+3.1%) |
| Jun 1996 | - | $237.80 M(+22.3%) | $841.00 M(+5.4%) |
| Mar 1996 | - | $194.40 M(-3.1%) | $798.10 M(+4.9%) |
| Dec 1995 | $760.80 M(+8.9%) | $200.70 M(-3.6%) | $760.80 M(+1.4%) |
| Sep 1995 | - | $208.10 M(+6.8%) | $750.40 M(+3.3%) |
| Jun 1995 | - | $194.90 M(+24.1%) | $726.40 M(+3.1%) |
| Mar 1995 | - | $157.10 M(-17.4%) | $704.50 M(+0.8%) |
| Dec 1994 | $698.50 M(+26.7%) | $190.30 M(+3.4%) | $698.60 M(+8.1%) |
| Sep 1994 | - | $184.10 M(+6.4%) | $646.20 M(+5.8%) |
| Jun 1994 | - | $173.00 M(+14.4%) | $610.90 M(+5.8%) |
| Mar 1994 | - | $151.20 M(+9.6%) | $577.60 M(+4.8%) |
| Dec 1993 | $551.20 M(+10.7%) | $137.90 M(-7.3%) | $551.30 M(-9.8%) |
| Sep 1993 | - | $148.80 M(+6.5%) | $611.50 M(+5.2%) |
| Jun 1993 | - | $139.70 M(+11.8%) | $581.40 M(+7.9%) |
| Mar 1993 | - | $124.90 M(-37.0%) | $538.60 M(+8.1%) |
| Dec 1992 | $498.10 M(+303.6%) | $198.10 M(+66.9%) | $498.10 M(+30.4%) |
| Sep 1992 | - | $118.70 M(+22.5%) | $381.90 M(+16.8%) |
| Jun 1992 | - | $96.90 M(+14.8%) | $326.90 M(+109.8%) |
| Mar 1992 | - | $84.40 M(+3.1%) | $155.80 M(+26.4%) |
| Dec 1991 | $123.40 M(+141.5%) | $81.90 M(+28.6%) | $123.30 M(+962.9%) |
| Sep 1991 | - | $63.70 M(-185.8%) | $11.60 M(-131.8%) |
| Jun 1991 | - | -$74.20 M(-243.0%) | -$36.50 M(-171.4%) |
| Mar 1991 | - | $51.90 M(-274.2%) | $51.10 M(+421.4%) |
| Mar 1991 | $51.10 M(+75.6%) | - | - |
| Dec 1990 | - | -$29.80 M(-291.0%) | $9.80 M(-80.9%) |
| Sep 1990 | - | $15.60 M(+16.4%) | $51.30 M(+26.4%) |
| Jun 1990 | - | $13.40 M(+26.4%) | $40.60 M(+40.5%) |
| Mar 1990 | $29.10 M(-706.3%) | $10.60 M(-9.4%) | $28.90 M(-164.9%) |
| Dec 1989 | - | $11.70 M(+138.8%) | -$44.50 M(+27.5%) |
| Sep 1989 | - | $4.90 M(+188.2%) | -$34.90 M(+71.1%) |
| Jun 1989 | - | $1.70 M(-102.7%) | -$20.40 M(+325.0%) |
| Mar 1989 | -$4.80 M(-14.3%) | -$62.80 M(-394.8%) | -$4.80 M(-135.3%) |
| Dec 1988 | - | $21.30 M(+9.8%) | $13.60 M(+130.5%) |
| Sep 1988 | - | $19.40 M(+12.1%) | $5.90 M(-755.6%) |
| Jun 1988 | - | $17.30 M(-139.0%) | -$900.00 K(-83.9%) |
| Mar 1988 | -$5.60 M(+300.0%) | -$44.40 M(-426.5%) | -$5.60 M(-132.7%) |
| Dec 1987 | - | $13.60 M(+7.9%) | $17.10 M(+51.3%) |
| Sep 1987 | - | $12.60 M(0.0%) | $11.30 M(+135.4%) |
| Jun 1987 | - | $12.60 M(-158.1%) | $4.80 M(-469.2%) |
| Mar 1987 | -$1.40 M(+55.6%) | -$21.70 M(-378.2%) | -$1.30 M(-127.7%) |
| Dec 1986 | - | $7.80 M(+27.9%) | $4.70 M(+135.0%) |
| Sep 1986 | - | $6.10 M(-6.2%) | $2.00 M(-41.2%) |
| Jun 1986 | - | $6.50 M(-141.4%) | $3.40 M(-950.0%) |
| Mar 1986 | -$900.00 K(-91.2%) | -$15.70 M(-407.8%) | -$400.00 K(-150.0%) |
| Dec 1985 | - | $5.10 M(-32.0%) | $800.00 K(-129.6%) |
| Sep 1985 | - | $7.50 M(+177.8%) | -$2.70 M(-69.0%) |
| Jun 1985 | - | $2.70 M(-118.6%) | -$8.70 M(-17.1%) |
| Mar 1985 | -$10.20 M(+24.4%) | -$14.50 M(-1006.3%) | -$10.50 M(+66.7%) |
| Dec 1984 | - | $1.60 M(+6.7%) | -$6.30 M(-20.3%) |
| Sep 1984 | - | $1.50 M(+66.7%) | -$7.90 M(-16.0%) |
| Jun 1984 | - | $900.00 K(-108.7%) | -$9.40 M(-8.7%) |
| Mar 1984 | -$8.20 M | -$10.30 M | -$10.30 M |
FAQ
- What is Amgen annual earnings before interest & taxes?
- What is the all time high annual EBIT for Amgen?
- What is Amgen annual EBIT year-on-year change?
- What is Amgen quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Amgen?
- What is Amgen quarterly EBIT year-on-year change?
- What is Amgen TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Amgen?
- What is Amgen TTM EBIT year-on-year change?
What is Amgen annual earnings before interest & taxes?
The current annual EBIT of AMGN is $7.76 B
What is the all time high annual EBIT for Amgen?
Amgen all-time high annual earnings before interest & taxes is $10.94 B
What is Amgen annual EBIT year-on-year change?
Over the past year, AMGN annual earnings before interest & taxes has changed by -$2.97 B (-27.64%)
What is Amgen quarterly earnings before interest & taxes?
The current quarterly EBIT of AMGN is $1.53 B
What is the all time high quarterly EBIT for Amgen?
Amgen all-time high quarterly earnings before interest & taxes is $3.98 B
What is Amgen quarterly EBIT year-on-year change?
Over the past year, AMGN quarterly earnings before interest & taxes has changed by -$144.00 M (-8.61%)
What is Amgen TTM earnings before interest & taxes?
The current TTM EBIT of AMGN is $7.76 B
What is the all time high TTM EBIT for Amgen?
Amgen all-time high TTM earnings before interest & taxes is $11.27 B
What is Amgen TTM EBIT year-on-year change?
Over the past year, AMGN TTM earnings before interest & taxes has changed by -$2.97 B (-27.64%)